logo

Switching From Haemonetics (NYSE: HAE) Into Oshkosh (NYSE: OSK) "Trading Transparency"
By: Bobs Advice for Stocks   Wednesday, August 05, 2009 9:22 AM

Vote for next session
The next market session will close:

Hello Friends!  Thanks so much for stopping by and visiting my blog, Stock Picks Bob's Advice!  As always, please remember that I am an amateur investor, so please remember to consult with your professional investment advisers prior to making any investment decisions based on information on this website.

As is part of my blogging, I wanted to share with you a 'swap' I made out of my position in Haemonetics (NYSE: ) and into Oshkosh (NYSE: ).  Both of these are mid cap stocks but that is where the similarity ends.  

On Monday, August 3, 2009, I sold my 50 shares of Haemonetics (HAE) at $55.08 after what I viewed as both technical weakness on somewhat less than stellar earnings, and purchased 80 shares of Oshkosh Corp (OSK) at $30.73 on what I viewed as compelling news on this 'old favorite' of mine and a nearby Wisconsin-based firm. Oshkosh (OSK) closed at $32.22 today, up $1.28 or 4.14% on the day...so I am already a few percentage points ahead on this purchase!

Haemonetics (HAE) is a stock I have purchased two times, originally picking up 50 shares on October 27, 2008, at a cost basis of $51.54, so I had a gain of $3.54 or 6.9% since purchase.  So it wasn't exactly a waste.  And I do need to develop more patience with all of my holdings!

Basically Haemonetics (HAE) reported 1st quarter earnings results yesterday.


Next Page >>123

(0)
No Comments
Post Comment
Name:  
Alert for new comments:
Your email:
Your Website:
Title:
Comments:
   
 
 
 
 
   
 

The above story is the opinion of the author only and it does not reflect iStockAnalyst opinion. Further, the author is not personally advising you regarding the suitability of the story for your investment needs. In no event iStockAnalyst will be liable for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from or arising out of, or in connection with the use of this information. Please consult your investment advisor before making any investment decision.
  
Advertisement
Popular Articles
Related Press Releases
Advertisement
Partner Center
Recent Articles by Bobs Advice for Stocks



Subscribe to Email Alerts rss feed or RSS feeds rss feed for articles from more than 500 contributors, press releases, SEC filings and full text news from more than four thousand sources.
Fundamental data is provided by Zacks Investment Research, market data is provided by AlphaTrade. , and Commentary and Press Releases provided by Quotemedia